期刊
BONE REPORTS
卷 11, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.bonr.2019.100226
关键词
MSCs; Testosterone; 17 beta-estradiol; Osteogenic differentiation; Adipogenic differentiation; Aromatase activity
资金
- German Research Foundation (Collaborative Research Centre TRR 79/SP B5, B11)
Progressive bone loss is a predominant symptom of aging and osteoporosis. Therefore, the effects of sex steroids (i.e. testosterone and 17 beta-estradiol) on the differentiation capacity of human bone-derived mesenchymal stromal cells (hMSCs), as progenitors of osteoblasts and adipocytes, are of particular interest. The objectives of the present study were, thus, to elucidate whether bone-derived hMSCs of postmenopausal women produce aromatase (CYP19A1) and, whether they modulate their differentiation behaviour in response to testosterone and 17 beta-estradiol (E2), in relation to their steroid receptor expression. Supplementation of testosterone resulted in a considerable formation of E2 under osteogenic and adipogenic culture conditions, whereas E2 synthesis remained minimal in the cells cultured in basal medium. Concomitant with high aromatase expression and 17 beta-estradiol formation of the cells cultured in osteogenic medium supplemented with testosterone, a distinct promotion of late-stage osteogenesis was found, as shown by significant matrix mineralization and a notable increase in osteogenic markers. These effects were abrogated by the aromatase inhibitor anastrozole. Under adipogenic conditions, testosterone reduced the occurrence of lipid droplets and led to a decrease in PPAR gamma and AR expression, independent of anastrozole. Regardless of the culture conditions, ER alpha was detectable whilst ER beta was not. In conclusion, aromatase activity is limited to differentiated hMSCs and the resulting 17 beta-estradiol enhances late osteogenic differentiation stages via ERa. Adipogenic differentiation, on the other hand, is reduced by both sex steroids: testosterone via AR and 17 beta-estradiol.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据